Tumor-associated macrophages: Shifting bad prognosis to improved efficacy in cancer therapies?
Open Access
- 15 May 2021
- journal article
- Published by Peertechz Publications Private Limited in International Journal of Immunotherapy and Cancer Research
- Vol. 7 (1), 015-023
- https://doi.org/10.17352/2455-8591.000032
Abstract
A few tumours are exceptionally stubborn to oral chemotherapy. The endurance of tumours in a few cases is helped by checkpoint immunomodulation to keep up the unevenness between resistant reconnaissance and disease cell division.Keywords
This publication has 100 references indexed in Scilit:
- A TrkB–STAT3–miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cellsMolecular Cancer, 2013
- ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophagesCell Research, 2013
- The Impact of the Myeloid Response to Radiation TherapyJournal of Immunology Research, 2013
- Expression of NF-κB p50 in Tumor Stroma Limits the Control of Tumors by Radiation TherapyPLOS ONE, 2012
- VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responsesThe Journal of Experimental Medicine, 2011
- Role for miR-204 in human pulmonary arterial hypertensionThe Journal of Experimental Medicine, 2011
- Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1The Journal of Experimental Medicine, 2009
- PD-L1: PD-1 Interaction Contributes to the Functional Suppression of T-Cell Responses to Human Uveal Melanoma Cells In VitroInvestigative Ophthalmology & Visual Science, 2008
- Macrophage activation by endogenous danger signalsThe Journal of Pathology, 2007
- Role of tumor-associated macrophages in tumor progression and invasionCancer and Metastasis Reviews, 2006